C

ChoA Pharmaceutical Co Ltd
KOSDAQ:034940

Watchlist Manager
ChoA Pharmaceutical Co Ltd
KOSDAQ:034940
Watchlist
Price: 901 KRW 1.35% Market Closed
Market Cap: ₩27.9B

Operating Margin

-14.2%
Current
Declining
by 4.2%
vs 3-y average of -10%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-14.2%
=
Operating Income
₩-8.6B
/
Revenue
₩60.5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-14.2%
=
Operating Income
₩-8.6B
/
Revenue
₩60.5B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
ChoA Pharmaceutical Co Ltd
KOSDAQ:034940
27.9B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

Lower than 84% of companies in Korea
Percentile
16th
Based on 2 615 companies
16th percentile
-14.2%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

ChoA Pharmaceutical Co Ltd
Glance View

Market Cap
27.9B KRW
Industry
Pharmaceuticals

ChoA Pharmaceutical Co., Ltd. engages in the manufacture and sale of medicine and health supplement food. The company is headquartered in Seoul, Seoul. The Company’s products are mainly for treatment of indigestion, gastric ulcer, duodenal ulcer, gastritis, gastric hyperacidity, intestinal disorder, constipation, diarrhea, stomachache, calcium deficiency, fatigue, iron deficiency anemia, neurasthenia, hypertension, hyperlipidemia, circulatory disorder, medicine poisoning, hepatic disease, allergic rhinitis, cough, cold, rheumatoid arthritis and others. The company also provides nutrition products, health drinks, mixed drinks, beverages for children, cosmetics and others.

Intrinsic Value
1 596.93 KRW
Undervaluation 44%
Intrinsic Value
Price
C
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-14.2%
=
Operating Income
₩-8.6B
/
Revenue
₩60.5B
What is ChoA Pharmaceutical Co Ltd's current Operating Margin?

The current Operating Margin for ChoA Pharmaceutical Co Ltd is -14.2%, which is below its 3-year median of -10%.

How has Operating Margin changed over time?

Over the last 3 years, ChoA Pharmaceutical Co Ltd’s Operating Margin has decreased from -6.1% to -14.2%. During this period, it reached a low of -16.3% on Mar 31, 2025 and a high of 1% on Jun 30, 2023.

Back to Top